News

Public screenings will take place at a variety of venues including private practices and hospitals in Austria, Belgium, Bulgaria, Greece, Italy, Spain and Switzerland.

Efficacy and safety of latanoprost in eyes with uveitic glaucoma

Pfizer and Bausch & Lomb are to co-promote their prescription eye drugs in the United States, allowing both companies to increase significantly the support for the products, according to a joint statement released by the companies.

Going Intrastromal: Refractive Surgery from the Inside Out

The Motion Displacement Test (MDT), developed by Moorfields Eye Hospital in partnership with UCL Institute of Ophthalmology and City University London will be on show during World Glaucoma Day (March 12th) to demonstrate some of the latest glaucoma diagnostic equipment.

The aspheric AcrySof IQ Toric intraocular lens (Alcon Inc) has been approved by the FDA, and will shortly be available to provide improved distance vision to patients with cataract and astigmatism.

Surgeons Get a Handle on Presbyopic Lenses

Scientists studying a neural retina in a salamander have found Müller cells in the promoted cone-specific pigment regeneration and dark adaptation that are independent of the pigment epithelium.

Infantile Hemangiomas and Retinopathy of Prematurity: Possible Association

Morphologic Changes in the Outer Layer of the Detached Retina in Rhegmatogenous Retinal Detachment and Central Serous Chorioretinopathy

Neuroprotective Effect of an Antioxidant, Lutein, during Retinal Inflammation

Laser burn to the retina of a single eye can compromise the immune privilege of the fellow eye.

Correction of astigmatism at the time of cataract surgery

Dr Tiziana Fattori of Per Vedere Fatti Vedere onlus in Italy explains the reasons behind the launch of a campaign to abolish bureaucratic procedures inhibiting patients from undertaking treatment for glaucoma.

GlaxoSmithKline (GSK) and University College London's Institute of Ophthalmology have agreed a deal in which the Institute will investigate the potential of compounds provided by GSK's ophthalmic unit, Ophthiris.

The retinal pigment epithelial (RPE) cell mosaic has been imaged for the first time in a living retina using an adaptive optics scanning laser ophthalmoscope (AOSLO), according to a report published in the March issue of Investigative Ophthalmology & Visual Science.

The recommendations for 'the use of single use instruments where possible' when performing 'high-risk' surgical procedures, has not only led to a growth in the single use market segment, but has stimulated massive reform in decontamination procedures, creating increased demand globally for reusable instruments due to new processes and longer lead times.

Ocular nutraceutical company, EyeScience Labs, LLC, has launched www.EyeScience.com that aims to meet the need for comprehensive information and education on age-related macular degeneration (AMD) in a watch-and-learn video format.

Chlamydia pneumoniae infection, complement factor H variants and AMD

Phakic intraocular lens for the correction of hyperopia

Ophthalmology Times Europe founding editor, Fedra Pavlou, is to become Editor-in-Chief of Pharmaceutical Technology Europe, another of Advanstar's publications. Pamela Brook joins the team as editor of OTE, with immediate effect.

Web-based, interactive approach for teaching the management of angle-closure glaucoma

Correction of residual hyperopia using light adjustable IOL technology

Wide field retinal imaging vs binocular indirect ophthalmoscopy for ROP screening

Abbott Laboratories has completed its acquisition of Advanced Medical Optics (AMO), paying $1.24 billion for 83% of the fully-diluted stock and assuming around $1.4 billion of AMO's long-term debt.

Wavefront-guided retreatment after primary wavefront-guided LASIK in Myopes and Hyperopes

Tube versus trabeculectomy

Low-dose proton beam therpay for circumscibed choroidal hemangiomas

Modified deep sclerectomy for primary open-angle glaucoma

ESBATech AG, a developer of antibody fragment therapeutics, has initiated a Phase IIa study in patients with acute anterior uveitis, designed to evaluate the safety, tolerability and clinical activity of topically applied ESBA105.